News for Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ)

Shield Therapeutics plc Investor Presentation H.C. Wainwright BIOCONNECT Virtual Conference ... | January 7, 2022

Shield Therapeutics plc US launch of Accrufer® confirmed for July 1, 2021 London, UK, June 24, 2021: Shield... | June 24, 2021

LONDON, June 21, 2021 (GLOBE NEWSWIRE) — Shield Therapeutics PLC (STX.L), based in Newcastle-upon-Tyne, UK, focused on addressing iron deficiency with its…